Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy

Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy

Introduction: This study aims to present the landscape of the intratumoral microenvironment and by which establish a classification system that can be used to predict the prognosis of bladder cancer patients and their response to anti-PD-L1 immunotherapy. Methods: The expression profiles of 1554 bla...

Full description

Bibliographic Details
Main Authors:	Zichen Bian, Jia Chen, Chang Liu, Qintao Ge, Meng Zhang, Jialin Meng, Chaozhao Liang
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Computational and Structural Biotechnology Journal
Subjects:	Bladder cancer Genomic Immunotherapy Overall survival
Online Access:	http://www.sciencedirect.com/science/article/pii/S2001037022005463

Similar Items

Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer
by: Xiangyu Zhang, et al.
Published: (2022-07-01)

Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy
by: Ezgi Değerli, et al.
Published: (2024-12-01)

Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer
by: Yucai Wu, et al.
Published: (2023-03-01)

Identification of 9-Core Immune-Related Genes in Bladder Urothelial Carcinoma Prognosis
by: Lei Na, et al.
Published: (2020-07-01)

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma
by: Huihuang Li, et al.
Published: (2022-09-01)

Clinical Characteristics and Prognosis of Rare Histological Variants of Bladder Cancer: A Single-Center Retrospective Study from China
by: Li D, et al.
Published: (2020-10-01)

Immune Microenvironment Terms Signature Robustly Predicts the Prognosis and Immunotherapy Response in Bladder Cancer Based on Large Population Cohorts
by: Shengjie Liang, et al.
Published: (2022-05-01)

Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma
by: Wang Q, et al.
Published: (2023-01-01)

Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer
by: Zhihao Yao, et al.
Published: (2022-09-01)

Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Bladder Cancer
by: Faping Li, et al.
Published: (2020-07-01)

Construction of T cell exhaustion model for predicting survival and immunotherapy effect of bladder cancer based on WGCNA
by: Yuwen Xue, et al.
Published: (2023-05-01)

Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis
by: Feng Li, et al.
Published: (2024-02-01)

Disulfidptosis and ferroptosis related genes define the immune microenvironment and NUBPL serves as a potential biomarker for predicting prognosis and immunotherapy response in bladder cancer
by: Xuezhou Zhang, et al.
Published: (2024-09-01)

Risk and prognosis of secondary bladder cancer after radiation therapy for pelvic cancer
by: Shuofeng Li, et al.
Published: (2022-08-01)

Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer
by: Zheng Liu, et al.
Published: (2018-09-01)

Editorial: Understanding bladder tumor microenvironment to optimize immunotherapy
by: Mathieu Rouanne, et al.
Published: (2025-02-01)

Delineation of colorectal cancer ligand-receptor interactions and their roles in the tumor microenvironment and prognosis
by: Hexin Lin, et al.
Published: (2021-12-01)

Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer
by: Renyu Liu, et al.
Published: (2024-08-01)

Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Bladder Cancer
by: Mengjia Huang, et al.
Published: (2021-08-01)

Development and validation a model for predicting overall survival of bladder cancer with lung metastasis: a population-based study
by: Liang Liu, et al.
Published: (2023-08-01)

A novel 17 apoptosis-related genes signature could predict overall survival for bladder cancer and its associations with immune infiltration
by: Yi Wang, et al.
Published: (2022-11-01)

Pyroptosis-Related Patterns Predict Tumor Immune Landscape and Immunotherapy Response in Bladder Cancer
by: Yilin Yan, et al.
Published: (2022-04-01)

SUMOylation Pattern Predicts Prognosis and Indicates Tumor Microenvironment Infiltration Characterization in Bladder Cancer
by: Qi-Dong Xia, et al.
Published: (2022-03-01)

Immune-related gene risk score predicting the effect of immunotherapy and prognosis in bladder cancer patients
by: Yuantao Zou, et al.
Published: (2022-10-01)

A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
by: Jinming Cai, et al.
Published: (2023-01-01)

Neoantigen immunotherapy: a novel treatment for bladder cancer
by: Ruiyang Lv, et al.
Published: (2025-01-01)

A Prognostic Nomogram Based on Log Odds of Positive Lymph Nodes to Predict Overall Survival for Non-Metastatic Bladder Cancer Patients after Radical Cystectomy
by: Jingtian Yang, et al.
Published: (2022-09-01)

Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response
by: Jingchao Liu, et al.
Published: (2022-02-01)

Classification of pediatric gliomas based on immunological profiling: implications for immunotherapy strategies
by: Zihao Wang, et al.
Published: (2021-03-01)

Predictive role of lactylation-related gene signature in the prognosis and immunotherapy response in bladder cancer
by: Guoyuan Liu, et al.
Published: (2025-02-01)

Tumour microenvironment landscape and immunotherapy response in bladder cancer decoded by stromal MOXD1 based on copper-related genes signature
by: Wenhao Wang, et al.
Published: (2022-12-01)

Risk and Prognosis of Secondary Bladder Cancer After Radiation Therapy for Rectal Cancer: A Large Population-Based Cohort Study
by: Xu Guan, et al.
Published: (2021-01-01)

The predictive value of PFKFB3 in bladder cancer prognosis
by: Dongxu Qiu, et al.
Published: (2024-05-01)

Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
by: Beatriz Ramos, et al.
Published: (2025-02-01)

Prediction of immunotherapy response of bladder cancer with a pyroptosis-related signature indicating tumor immune microenvironment
by: Zihan Xu, et al.
Published: (2024-06-01)

Construction and verification of a novel hypoxia-related lncRNA signature related with survival outcomes and immune microenvironment of bladder urothelial carcinoma by weighted gene co-expression network analysis
by: Dawei Cai, et al.
Published: (2022-08-01)

The Immune Cell Infiltration Patterns and Characterization Score in Bladder Cancer to Identify Prognosis
by: Yongsheng Zhang, et al.
Published: (2022-06-01)

Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
by: Ashish M. Kamat, et al.
Published: (2017-08-01)

Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer
by: Rui Cao, et al.
Published: (2021-09-01)

The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who do not receive definitive surgery of the tumor
by: Saber Amin, et al.
Published: (2020-09-01)